Cabergoline and fall Patient Reports February 12, 2012

Cabergoline Side Effects Report #4642265-7
Cabergoline side effect was reported by a Health Professional from on Apr 07, 2005. Male patient, 82 years of age, weighting 136.7 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: abdominal mass, constipation , fall , spinal compression fracture. Cabergoline dosage: 0.25 MG (0.25 MG, DAILY), ORAL. During the same period patient was treated with SINEMET, CHLORMADINONE ACETATE, TAMSULOSIN HYDROCHLROIDE, STREPTOCOCCUS FAECALIS, CLONAZEPAM, TRIMEBUTINE MALEATE, MAGENSIUM OXIDE, DOMPERIDONE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #5335268-0
Cabergoline side effect was reported by a Consumer or non-health professional from JAPAN on May 14, 2007. Female patient, 78 years of age, was diagnosed with parkinson's disease , infection prophylaxis and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: abdominal distension, blood pressure decreased, constipation , diarrhoea, fall , jaw fracture, pseudomembranous colitis, septic shock. Cabergoline dosage: unknown. During the same period patient was treated with FLOMOX, PANIPENEM, SELEGILINE HYDROCHLORIDE. Patient was hospitalized. Patient died on 01/07/2006.

Cabergoline Side Effects Report #4594907-2
Cabergoline side effect was reported by a Physician from on Feb 10, 2005. Male patient, 76 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: ascites, congestive cardiomyopathy, fall , oedema peripheral, tricuspid valve incompetence. Cabergoline dosage: unknown. During the same period patient was treated with BROMOCRIPTINE MESYLATE, NULYTELY, FUROSEMIDE, ASPIRIN, SPIRONOLACTONE, MADOPAR, SOTALOL, LEKOVIT CA. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4645531-4
Cabergoline side effect was reported by a Pharmacist from on Apr 13, 2005. Male patient, 72 years of age, weighting 149.9 lb, was diagnosed with parkinson's disease , toothache and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, depressed level of consciousness, fall . Cabergoline dosage: unknown. During the same period patient was treated with BUFFERIN, AMLODIPINE BESYLATE, SINEMET. Patient was hospitalized. Patient recovered.


Cabergoline Side Effects Report #4655902-8
Cabergoline side effect was reported by a Pharmacist from on Apr 22, 2005. Male patient, 72 years of age, weighting 149.9 lb, was diagnosed with parkinson's disease , toothache and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, c-reactive protein increased, depressed level of consciousness, fall , incoherent, pyrexia, toothache, white blood cell count increased. Cabergoline dosage: unknown. During the same period patient was treated with BUFFERIN, AMLODIPINE BESYLATE, SINEMET. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4911994-X
Cabergoline side effect was reported by a Physician from AUSTRALIA on Feb 03, 2006. Male patient, 72 years of age, weighting 140.0 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: cervical vertebral fracture, condition aggravated, delusion, fall , hypoxic encephalopathy, paranoia, parkinson's disease , physical assault. Cabergoline dosage: (2 MG), ORAL. During the same period patient was treated with COMTAN, ZESTRIL, MICARDIS HCT, SINEMET, ARTANE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4551652-7
Cabergoline side effect was reported by a Health Professional from on Dec 28, 2004. Male patient, 71 years of age, weighting 110.2 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, cerebral haemorrhage traumatic, contusion, fall , gait disturbance, hypokinesia, masked facies, muscle rigidity, myoglobin blood increased. Cabergoline dosage: 0.25 MG (0.25 MG 1 IN 1 D ) ORAL. During the same period patient was treated with MADOPAR, BENIDIPINE HYDROCHLORIDE, BISOPROLOL FUMARATE, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4579808-8
Cabergoline side effect was reported by a Consumer or non-health professional from on Jan 31, 2005. Male patient, 71 years of age, weighting 110.2 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, cerebral haemorrhage traumatic, contusion, fall , flat affect, gait disturbance, hypokinesia, muscle rigidity, myoglobin blood increased. Cabergoline dosage: 0.25 MG (0.25 MG 1 IN 1D ) ORAL. During the same period patient was treated with MADOPAR, BENIDIPINE HYDROCHLORIDE, BISOPROLOL FUMARATE, AMLODIPINE BESYLATE. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4639512-4
Cabergoline side effect was reported by a Pharmacist from on Apr 05, 2005. Male patient, 70 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, fall . Cabergoline dosage: 2.5 MG (2.5 MG, 1 IN 1 D), ORAL. During the same period patient was treated with SINEMET, ASPIRIN. Patient was hospitalized. Patient recovered.


Cabergoline Side Effects Report #4562657-4
Cabergoline side effect was reported by a Physician from on Jan 12, 2005. Female patient, 68 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood creatine phosphokinase increased, depressed level of consciousness, dysphagia, fall , grand mal convulsion, hallucination, hepatic function abnormal, mobility decreased. Cabergoline dosage: 0.25 MG, ORAL. During the same period patient was treated with PERGOLIDE MESYLATE, MAPROTILINE, SINEMET, AMANTADINE, FUROSEMIDE, SPIRONOLACTONE, ETIZOLAM. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4954490-6
Cabergoline side effect was reported by a Physician from JAPAN on Mar 10, 2006. Female patient, 66 years of age, weighting 142.9 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: fall , purpura, thrombocytopenia. Cabergoline dosage: 0.25 MG (0.25 MG, 1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4968219-9
Cabergoline side effect was reported by a Physician from JAPAN on Mar 24, 2006. Female patient, 66 years of age, weighting 142.9 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood disorder, fall , purpura, thrombocytopenia. Cabergoline dosage: 0.25 MG (0.25 MG, 1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4968270-9
Cabergoline side effect was reported by a Physician from JAPAN on Mar 24, 2006. Female patient, 66 years of age, weighting 142.9 lb, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: blood disorder, fall , purpura, thrombocytopenia. Cabergoline dosage: 0.25 MG (0.25 MG, 1 IN 1 D), ORAL. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4659599-2
Cabergoline side effect was reported by a Consumer or non-health professional from on Apr 27, 2005. Male patient, 54 years of age, was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: coronary artery insufficiency, fall . Cabergoline dosage: unknown. During the same period patient was treated with SINEMET, ENTACAPONE. Patient died.


Cabergoline Side Effects Report #5133765-4
Cabergoline side effect was reported by a Physician from GERMANY on Oct 05, 2006. Male patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: condition aggravated, dizziness , fall , fatigue, gait disturbance, illusion. Cabergoline dosage: 1.5 MG (1 D), ORAL. During the same period patient was treated with MADOPAR. Patient recovered.

Cabergoline Side Effects Report #4613211-7
Cabergoline side effect was reported by a Pharmacist from on Mar 02, 2005. Male patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: dyspnoea, fall . Cabergoline dosage: unknown. Patient was hospitalized. Patient recovered.

Cabergoline Side Effects Report #4640681-0
Cabergoline side effect was reported by a Physician from on Apr 06, 2005. Female patient was diagnosed with parkinson's disease  and was treated with Cabergoline. After drug was administered, patient experienced the following side effects: accident, eye injury, fall , fracture . Cabergoline dosage: 4 MG (2 MG, EVERY DAY), ORAL. During the same period patient was treated with SINEMET. Patient was hospitalized. Patient recovered.